Literature DB >> 3551602

Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension.

R Zusman, D Christensen, E Federman, M S Kochar, D McCarron, J G Porush, S Spitalewitz.   

Abstract

One hundred patients participated in a double-blind, randomized study to compare the antihypertensive efficacy of sustained-release nifedipine and propranolol in hypertensive patients whose diastolic blood pressure exceeded 95 mm Hg while receiving diuretic therapy. Nifedipine (mean dose, 79.6 mg per day) decreased blood pressure by 11.4/10.5 mm Hg; propranolol (mean dose, 198.4 mg per day) decreased blood pressure by 13.5/10.3 mm Hg. Reduction of diastolic blood pressure to below 90 mm Hg was achieved in 63 percent of nifedipine-treated patients and in 57 percent of propranolol-treated patients. Nifedipine therapy was associated with an increase in high-density lipoprotein cholesterol levels and a decrease in serum triglyceride levels. In contrast, propranolol therapy was associated with a decrease in high-density lipoprotein cholesterol levels and an increase in serum triglyceride levels. Nifedipine is as effective as propranolol in the treatment of patients with mild to moderate hypertension whose blood pressure is inadequately controlled by diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551602     DOI: 10.1016/0002-9343(87)90209-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

2.  Behavioral performance effects of nifedipine in normotensive and renovascular hypertensive baboons.

Authors:  J S Turkkan; R D Hienz
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: a controlled study versus placebo.

Authors:  L A Ferrara; T Marotta; F Pasanisi; P Mastranzo; M Mancini
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

4.  New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.

Authors:  Ilknur Kozanoglu; Melis Kartal Yandim; Zeynep Birsu Cincin; Hakan Ozdogu; Bedia Cakmakoglu; Yusuf Baran
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-19       Impact factor: 4.553

5.  Comparison of nisoldipine and nifedipine as additional treatment in hypertension inadequately controlled by atenolol.

Authors:  B I Hoffbrand; K A Earle; J G Nievel; L J Restrick; N J Simmonds
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

Review 6.  Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.

Authors:  Katherine F Croom; Keri Wellington
Journal:  Drugs       Date:  2006       Impact factor: 11.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.